Company profile: Starpharma
1.1 - Company Overview
Company description
- Provider of dendrimer-based therapeutics and delivery technologies, including the DEP drug delivery platform to enhance effectiveness and reduce toxicities via controlled delivery; VIRALEZE, a topical antiviral nasal spray registered in 35+ countries; VivaGel BV, a non-antibiotic vaginal gel for treatment and prevention of bacterial vaginosis registered in 50+ countries; collaborates with biopharma partners.
Products and services
- DEP drug delivery platform: Custom-engineered controlled-delivery system that enhances effectiveness and reduces toxicities of existing and novel therapies through controlled drug delivery
- VivaGel BV: Non-antibiotic vaginal gel engineered for treatment and prevention of bacterial vaginosis, registered in over 50 countries for women’s health applications
- VIRALEZE: Topical antiviral nasal spray, registered in over 35 countries, architected for nasal delivery and antiviral activity for unspecified indications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Starpharma
Gold Standard Simulations
HQ: United Kingdom
Website
- Description: Provider of simulation of statistical variability in nano-CMOS devices, offering complete solutions for Design Technology Co-Optimisation (DTCO), PDK development, and exploration and screening of future technology options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gold Standard Simulations company profile →
Oxford Nanopore
HQ: United Kingdom
Website
- Description: Provider of electronics-based nanopore DNA/RNA sequencing technology used in more than 80 countries for biological research, including large-scale human genomics, cancer research, and microbiology. Portfolio includes devices from portable to ultra-high throughput: MinION, GridION, PromethION, the Flongle adapter, forthcoming SmidgION mobile device, and VolTRAX for automated sample and library preparation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oxford Nanopore company profile →
Bruker Alicona
HQ: Austria
Website
- Description: Provider of optical 3D surface measurement technology for quality assurance in laboratories and production. Offers optical 3D metrology and Focus-Variation technology for non-contact, high-resolution 3D measurements, bridging coordinate metrology and surface roughness measurement. Products include µCMM, InfiniteFocus G6, InfiniteFocusSL, and Real3DUnitX to measure dimensions, position, shape, and roughness of complex components.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bruker Alicona company profile →
Protiva Bio
HQ: United States
Website
- Description: Provider of nucleic acid-based pharmaceutical products targeting human diseases, including cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections; includes Pro 1, a tumor cell growth inhibitor.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Protiva Bio company profile →
Hysitron
HQ: United States
Website
- Description: Provider of nanomechanical test instrumentation, developing, manufacturing, selling, and servicing cutting-edge instruments for the scientific community, featuring in-situ imaging with nanomechanical property measurement capabilities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hysitron company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Starpharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Starpharma
2.2 - Growth funds investing in similar companies to Starpharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Starpharma
4.2 - Public trading comparable groups for Starpharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →